Pharmaniaga BhdXKLS:7081 46 Operating Margin % is 4.67% as of Mar. 2026, which is 23% above its 10-year median of 3.81. GuruFocus rates XKLS:7081 with a GF Score™ of 46/100 and a GF Value™ of RM0.76 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 117 Medical Distribution companies, Pharmaniaga Bhd ranks better than 50.43% on this metric.
The historical rank and industry rank for Pharmaniaga Bhd's Operating Margin % or its related term are showing as below:
XKLS:7081'
s Operating Margin % Range Over the Past 10 Years
Min: -15.05 Med: 3.81 Max: 6.95
Current: 3.07
XKLS:7081's Operating Margin % is ranked better than 50.43% of 117
companies
in the Medical Distribution industry
Industry Median: 3.05
vs XKLS:7081: 3.07
Pharmaniaga Bhd's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Pharmaniaga Bhd (XKLS:7081) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Pharmaniaga Bhd Operating Margin % Related Terms
Pharmaniaga Bhd Operating Margin % Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7081 vs MCK, CAH, COR: Operating Margin % Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Operating Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Pharmaniaga Bhd's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Operating Margin % of 4.67% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Pharmaniaga Bhd and its competitors. This is 23% above median its historical median of 3.81. According to the industry distribution chart, Pharmaniaga Bhd ranks #58 out of 117 companies in the Medical Distribution industry, placing it in the top 49.6%.
Is Pharmaniaga Bhd's Operating Margin % too high?
Pharmaniaga Bhd's current Operating Margin % of 4.67% is 23% above median its 10-year median of 3.81. The Medical Distribution industry median Operating Margin % is 3.05. Pharmaniaga Bhd's value of 4.67% is 53.1% above this industry median. Based on the distribution chart, Pharmaniaga Bhd ranks #58 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Pharmaniaga Bhd has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Operating Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #58 out of 117 companies for Operating Margin %. This puts Pharmaniaga Bhd in the upper half of its industry. The industry median Operating Margin % is 3.05. Pharmaniaga Bhd's value of 4.67% is 53.1% above this benchmark. While the company's 10-year median is 3.81 vs. the industry median of 3.05, Pharmaniaga Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Distribution company?
The median Operating Margin % among Medical Distribution companies is 3.05, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmaniaga Bhd's current Operating Margin % of 4.67% is 53.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median Operating Margin % is 3.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current Operating Margin % is 4.67%, which is 23% above median its own 10-year median of 3.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.76, compared to a current price of RM1.18 — trading 55.3% above its estimated fair value. The current Operating Margin % is 4.67%, which is 23% above median its 10-year median of 3.81 and 53.1% above the Medical Distribution industry median of 3.05. Pharmaniaga Bhd's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Operating Margin % is 4.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.18 is trading 55.3% above its estimated GF Value™ of RM0.76.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Operating Margin %: 4.67% (23% above median its 10-year median of 3.81)
GF Value™: RM0.76 vs. price of RM1.18 (55.3% above fair value)
Industry Position: 53.1% above the Medical Distribution median (#58 of 117)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
46GF Score
Get the complete analysis for XKLS:7081
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
